Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

561 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Transcriptomic profiling of the myeloma bone-lining niche reveals BMP signalling inhibition to improve bone disease.
Gooding S, Olechnowicz SWZ, Morris EV, Armitage AE, Arezes J, Frost J, Repapi E, Edwards JR, Ashley N, Waugh C, Gray N, Martinez-Hackert E, Lim PJ, Pasricha SR, Knowles H, Mead AJ, Ramasamy K, Drakesmith H, Edwards CM. Gooding S, et al. Among authors: ramasamy k. Nat Commun. 2019 Oct 4;10(1):4533. doi: 10.1038/s41467-019-12296-1. Nat Commun. 2019. PMID: 31586071 Free PMC article.
Managing multiple myeloma in the over 70s: a review.
King AJ, Gooding S, Ramasamy K. King AJ, et al. Among authors: ramasamy k. Maturitas. 2015 Feb;80(2):148-54. doi: 10.1016/j.maturitas.2014.11.017. Epub 2014 Dec 2. Maturitas. 2015. PMID: 25541475 Review.
Myeloma clinical outcomes following the first wave of COVID-19: results from the Thames Valley Cancer Alliance (UK).
Sharpley FA, Larham J, Haines A, Djebbari F, Tseu B, Leary H, Vallance G, Panitsas F, Ferguson L, Roberts P, Peniket A, Gooding S, Kothari J, Moore S, Ramasamy K. Sharpley FA, et al. Among authors: ramasamy k. Br J Haematol. 2021 Mar;192(6):e136-e139. doi: 10.1111/bjh.17261. Epub 2020 Dec 16. Br J Haematol. 2021. PMID: 33326594 Free article. No abstract available.
COVID symptoms, testing, shielding impact on patient-reported outcomes and early vaccine responses in individuals with multiple myeloma.
Ramasamy K, Sadler R, Jeans S, Varghese S, Turner A, Larham J, Gray N, Barrett J, Bowcock S, Cook G, Kyriakou C, Smith D, Drayson M, Basu S, Moore S, McDonald S, Gooding S, Javaid MK. Ramasamy K, et al. Br J Haematol. 2022 Jan;196(1):95-98. doi: 10.1111/bjh.17764. Epub 2021 Aug 2. Br J Haematol. 2022. PMID: 34341984 Free PMC article. No abstract available.
Immune response to COVID-19 vaccination is attenuated by poor disease control and antimyeloma therapy with vaccine driven divergent T-cell response.
Ramasamy K, Sadler R, Jeans S, Weeden P, Varghese S, Turner A, Larham J, Gray N, Carty O, Barrett J, Bowcock S, Oppermann U, Cook G, Kyriakou C, Drayson M, Basu S, Moore S, McDonald S, Gooding S, Javaid MK. Ramasamy K, et al. Br J Haematol. 2022 May;197(3):293-301. doi: 10.1111/bjh.18066. Epub 2022 Feb 17. Br J Haematol. 2022. PMID: 35064676 Free PMC article.
Myeloma Genome Project Panel is a Comprehensive Targeted Genomics Panel for Molecular Profiling of Patients with Multiple Myeloma.
Sudha P, Ahsan A, Ashby C, Kausar T, Khera A, Kazeroun MH, Hsu CC, Wang L, Fitzsimons E, Salminen O, Blaney P, Czader M, Williams J, Abu Zaid MI, Ansari-Pour N, Yong KL, van Rhee F, Pierceall WE, Morgan GJ, Flynt E, Gooding S, Abonour R, Ramasamy K, Thakurta A, Walker BA. Sudha P, et al. Among authors: ramasamy k. Clin Cancer Res. 2022 Jul 1;28(13):2854-2864. doi: 10.1158/1078-0432.CCR-21-3695. Clin Cancer Res. 2022. PMID: 35522533 Free PMC article.
561 results